The gene profile that identified the two subtypes of HPV+ HNSCC was based on high or low NF-κB signaling and fully recapitulated previous subtypes that our group defined based on the presence or absence of inactivating defects in TRAF3 or CYLD or associated gene expression changes [64,65,73]. This evidence concerns the gene TRAF3 and head and neck squamous cell carcinoma.